Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Viridian Therapeutics Inc (VRDN)

Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,351,750
  • Shares Outstanding, K 63,822
  • Annual Sales, $ 310 K
  • Annual Income, $ -237,730 K
  • 60-Month Beta 1.03
  • Price/Sales 4,386.84
  • Price/Cash Flow N/A
  • Price/Book 4.27
Trade VRDN with:

Options Overview Details

View History
  • Implied Volatility 65.12% ( -0.41%)
  • Historical Volatility 94.19%
  • IV Percentile 16%
  • IV Rank 22.45%
  • IV High 193.07% on 08/13/24
  • IV Low 28.08% on 05/22/24
  • Put/Call Vol Ratio 1.38
  • Today's Volume 186
  • Volume Avg (30-Day) 1,465
  • Put/Call OI Ratio 1.16
  • Today's Open Interest 28,960
  • Open Int (30-Day) 19,647

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -1.09
  • Number of Estimates 7
  • High Estimate -0.93
  • Low Estimate -1.17
  • Prior Year -1.09
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.20 +60.30%
on 09/05/24
23.80 -11.09%
on 09/16/24
+5.67 (+36.60%)
since 08/16/24
3-Month
11.79 +79.47%
on 06/20/24
23.80 -11.09%
on 09/16/24
+8.98 (+73.73%)
since 06/18/24
52-Week
10.93 +93.68%
on 10/25/23
24.18 -12.49%
on 01/09/24
+3.88 (+22.45%)
since 09/18/23

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Viridian Therapeutics Inc. is a biotechnology company advancing new treatments for patients suffering from serious diseases. The company's program includes VRDN-001, which is in clinical stage. Viridian Therapeutics Inc., formerly known as miRagen Therapeutics Inc., is based in BOULDER, Colo.

See More

Key Turning Points

3rd Resistance Point 23.35
2nd Resistance Point 22.70
1st Resistance Point 21.94
Last Price 21.27
1st Support Level 20.53
2nd Support Level 19.88
3rd Support Level 19.12

See More

52-Week High 24.18
Last Price 21.27
Fibonacci 61.8% 19.12
Fibonacci 50% 17.55
Fibonacci 38.2% 15.99
52-Week Low 10.93

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar